Coya Therapeutics, Inc. (COYA)
NASDAQ: COYA · Real-Time Price · USD
4.840
+0.050 (1.04%)
At close: Mar 9, 2026, 4:00 PM EDT
4.840
0.00 (0.00%)
After-hours: Mar 9, 2026, 4:10 PM EDT

Coya Therapeutics Revenue

Coya Therapeutics had revenue of $3.56M in the quarter ending September 30, 2025. This brings the company's revenue in the last twelve months to $3.99M, down -58.26% year-over-year. In the year 2024, Coya Therapeutics had annual revenue of $3.55M, down -40.79%.

Revenue (ttm)
$3.99M
Revenue Growth
-58.26%
P/S Ratio
28.66
Revenue / Employee
$498,463
Employees
8
Market Cap
113.48M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20243.55M-2.45M-40.79%
Dec 31, 20236.00M--
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 2020---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Fortress Biotech 62.30M
Codexis 52.93M
Gossamer Bio 44.05M
Korro Bio 7.37M
Equillium 4.39M
Precision BioSciences 698.00K
Inovio Pharmaceuticals 182.34K
Genelux 8.00K
Revenue Rankings